NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM7234363 Query DataSets for GSM7234363
Status Public on Sep 27, 2023
Title SEM_PINO_RES_DOT1Li_biol rep 4 RNA
Sample type SRA
 
Source name cell line
Organism Homo sapiens
Characteristics tissue: cell line
cell line: Acute Lymphoblastic Leukemia cell line SEM
cell type: Paediatric pro B-cell line derived from ALL with t(4;11)(q21;q23) translocation
genotype: t(4;11)(q21;q23) translocation
treatment: 50uM pinometostat for 7 days
Treatment protocol SEM and SEMPINORES cells were cultured in the presence of 50 µM of the DOT1L inhibitor pinometostat (EPZ5676, Selleckchem) for 1 week, with passage of the cells after 3 days with fresh inhibitor
Growth protocol SEM and SEMPINORES cells were continuously grown in in RPMI-1640 medium containing GlutaMAXTM supplemented with 10% fetal calf serum, 100 IU/ml Penicillin and Streptomycin, and 0.125µg/ml Amphotericin B (Life Technologies), at 37°C under a 5% CO2 containing atmosphere. Cell lines passed every 3-4 days and routinely tested for the absence of mycoplasma and DNA fingerprinted to assure cell line authenticity.
Extracted molecule total RNA
Extraction protocol RNA was isolated from leukemic cells using the RNeasy Mini Kit (Qiagen)
Libraries were generated using the TruSeq Stranded mRNA library preparation kit (Illumina, RS-122-2103)
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina NextSeq 500
 
Description SEM_vs_PINO_RES_DEGs_CPM.txt
SEM_vs_PINO_RES_featureCounts.txt
Data processing QC was performed with fastQC
reads were trimmed with trim_galore, then aligned against the human genome assembly (hg19) with STAR
read counts were used to identify differential gene expression using DESeq2 (v3.12)
Gene expression levels were quantified using the featureCounts function of the Subread package
Differential gene expression analysis was conducted using DEseq2
Assembly: hg19
Supplementary files format and content: logFC and CPM
Supplementary files format and content: featureCounts output
 
Submission date Apr 27, 2023
Last update date Sep 27, 2023
Contact name Ronald W. Stam
E-mail(s) r.w.stam@prinsesmaximacentrum.nl
Organization name Prinses Maxima Centrum
Street address Heidelberglaan 25
City Utrecht
ZIP/Postal code 3702 VK
Country Netherlands
 
Platform ID GPL18573
Series (2)
GSE230791 Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged Acute Lymphoblastic Leukemia’ [RNA-seq]
GSE230807 Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged Acute Lymphoblastic Leukemia’
Relations
BioSample SAMN34411292
SRA SRX20121270

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap